Overview

Comparison of Bolus Dosing of Methohexital and Propofol in Elective Direct Current Cardioversion

Status:
Recruiting
Trial end date:
2021-11-01
Target enrollment:
Participant gender:
Summary
A randomized, open-blinded, prospective study to evaluate the timeliness and safety of direct current cardioversion (DCCV) when using methohexital when compared to the more often used propofol.
Phase:
Phase 4
Details
Lead Sponsor:
Wake Forest University Health Sciences
Treatments:
Methohexital
Propofol